[Diabetes insipidus. Physiopathological and therapeutic classification in the light of recent advances].
D000293:Adolescent; D000328:Adult; D000368:Aged; D002747:Chlorpropamide / Q000627:therapeutic use; D002994:Clofibrate / Q000627:therapeutic use; D003919:Diabetes Insipidus / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D003984:Dibenzazepines / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007031:Hypothalamus / Q000503:physiopathology; D007668:Kidney / Q000503:physiopathology; D007677:Kidney Function Tests; D008297:Male; D008875:Middle Aged; D010904:Pituitary Gland, Posterior / Q000503:physiopathology; D010909:Pituitary Hormones, Posterior / Q000627:therapeutic use; D014667:Vasopressins / Q000378:metabolism*; D014867:Water / Q000378:metabolism
D003984:Dibenzazepines; D004232:Diuretics; D010909:Pituitary Hormones, Posterior; D014867:Water; D014667:Vasopressins; D002994:Clofibrate; D002747:Chlorpropamide
Il diabete insipido. Inquadramento fisiopatologico e terapeutico alla luce delle più recenti acquisizioni